Evaluation of Safety and Efficacy of Nebulizer Delivering Drugs in Lung Disease Patient: A Prospective Cohort Study

Respiratory disease, including asthma and Chronic Obstructive Pulmonary Disease (COPD), presents significant challenges in patient management and quality of life. Nebulizers are commonly used to deliver inhaled medications directly to the lungs, offering advantages for patients who struggle with traditional inhalers. However, the safety and efficacy of nebulizer treatments require thorough evaluation. This prospective cohort study aims to assess patient-reported outcomes, adherence to treatment regimens, and any adverse effects associated with nebulizer use. By analyzing these factors, the research seeks to inform clinical practices, enhance patient education, and develop guidelines to optimize the use of nebulizers in lung disease management. The study is on prospective observational cohort study was carried at a tertiary care hospital in erode, focusing on the nebulizer use patients for lung disease over a period of 9 months; the estimated sample size is 157 in were 22 patients were not involved in follow-up data were collected based on the questionnaires. The questioner is in 3section disease based, efficacy of drug and safety maintenance. In my study out of 157 patients, a male patient is highly affected by the respiratory disease. In hospital, 68% of the patient used the continuous nebulization. Albuterol drug is effective for asthma patients and combination of ipratropium bromide and levosalbutamol is effective in cod patients. Continuous nebulizer therapy in optimizing outcomes for respiratory patients and highlight the need for ongoing support to ensure patient comfort and satisfaction. My finding the use of albuterol for asthma and the combination of ipratropium bromide and levosalbutamol for COPD highlight the importance of proper medication use in enhancing clinical outcomes.